Literature DB >> 19264533

Biocatalysis in development of green pharmaceutical processes.

Junhua Tao1, Jian-He Xu.   

Abstract

Biocatalysis is one of the greenest technologies for the synthesis of chiral molecules due to exquisite regioselectivity and stereoselectivity in water under mild conditions. For example, protection and deprotection of functional groups are usually not required for biotransformations, high or low temperature reactions can often be circumvented and usage of organic solvents are drastically minimized. To truly empower the green chemistry feature of biocatalysis, it is essential to integrate enzymatic transformations strategically into chemical transformations at the retrosynthetic level. This review focuses on the development of novel biocatalytic pharmaceutical processes to replace chemical routes with poorer process efficiency and higher manufacturing costs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264533     DOI: 10.1016/j.cbpa.2009.01.018

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  17 in total

1.  The dynamic influence of cells on the formation of stable emulsions in organic-aqueous biotransformations.

Authors:  Jonathan Collins; Marcel Grund; Christoph Brandenbusch; Gabriele Sadowski; Andreas Schmid; Bruno Bühler
Journal:  J Ind Microbiol Biotechnol       Date:  2015-04-28       Impact factor: 3.346

2.  Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis.

Authors:  David P Nannemann; William R Birmingham; Robert A Scism; Brian O Bachmann
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

3.  Using chemobiosynthesis and synthetic mini-polyketide synthases to produce pharmaceutical intermediates in Escherichia coli.

Authors:  Hugo G Menzella; John R Carney; Yong Li; Daniel V Santi
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

4.  Engineering Kinases to Phosphorylate Nucleoside Analogs for Antiviral and Cancer Therapy.

Authors:  Stefan Lutz; Lingfeng Liu; Yichen Liu
Journal:  Chimia (Aarau)       Date:  2009-11-01       Impact factor: 1.509

5.  Biocatalytic deracemisation of aliphatic β-hydroxy esters: improving the enantioselectivity by optimisation of reaction parameters.

Authors:  Sowmyalakshmi Venkataraman; Anju Chadha
Journal:  J Ind Microbiol Biotechnol       Date:  2014-12-05       Impact factor: 3.346

Review 6.  Recent Advances in Lipase-Mediated Preparation of Pharmaceuticals and Their Intermediates.

Authors:  Ana Caroline Lustosa de Melo Carvalho; Thiago de Sousa Fonseca; Marcos Carlos de Mattos; Maria da Conceição Ferreira de Oliveira; Telma Leda Gomes de Lemos; Francesco Molinari; Diego Romano; Immacolata Serra
Journal:  Int J Mol Sci       Date:  2015-12-11       Impact factor: 5.923

7.  Elucidation of the regio- and chemoselectivity of enzymatic allylic oxidations with Pleurotus sapidus - conversion of selected spirocyclic terpenoids and computational analysis.

Authors:  Verena Weidmann; Mathias Schaffrath; Holger Zorn; Julia Rehbein; Wolfgang Maison
Journal:  Beilstein J Org Chem       Date:  2013-10-29       Impact factor: 2.883

Review 8.  Nitrilases in nitrile biocatalysis: recent progress and forthcoming research.

Authors:  Jin-Song Gong; Zhen-Ming Lu; Heng Li; Jin-Song Shi; Zhe-Min Zhou; Zheng-Hong Xu
Journal:  Microb Cell Fact       Date:  2012-10-30       Impact factor: 5.328

9.  Laccase catalyzed synthesis of iodinated phenolic compounds with antifungal activity.

Authors:  Julian Ihssen; Mark Schubert; Linda Thöny-Meyer; Michael Richter
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

10.  Biocatalytic synthesis of chiral alcohols and amino acids for development of pharmaceuticals.

Authors:  Ramesh N Patel
Journal:  Biomolecules       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.